Researchers Identify Link Between Lactylation and Lung Cancer Progression and Treatment Resistance

Researchers from Shanghai Pulmonary Hospital have identified a significant link between lactylation, a novel post-translational modification, and the progression of lung cancer, as well as its resistance to treatment. The findings, published in *Current Molecular Pharmacology*, highlight the role of lactylation in cancer metabolism and epigenetics, offering new insights into the mechanisms driving tumor growth and therapy challenges.

The study, led by Yong Xu, provides an in-depth review of how lactylation influences cellular processes in lung cancer. Lactylation is described as a chemical modification that occurs after protein synthesis and has been found to impact gene expression and metabolic pathways within cancer cells. Researchers noted that this modification contributes to the aggressive behavior of lung tumors and their ability to evade therapeutic interventions. By examining existing data on lactylation’s role in cancer biology, the team aims to shed light on its potential implications for understanding disease progression and developing future treatments.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 7, 2026

Author

GOAI